Buprenorphine with Quantitative Confirmation, Urine

Last Modified: 6/20/2019 10:51:52 AM


Specimen Requirements: 10.0 mL Random Urine in a Yellow Capped Cup
Minimum Volume: 5.0 mL Urine
Transport & Storage: Temperature/Stability: 5 days Ambient
7 days Refrigerated
30 days Frozen
Rejection Criteria: Preserved urine
Reference Range:

Not established
Reference range is negative for patients not prescribed drug
Methodology: Screen: Immunoassay (IA) • Confirmation: Mass Spectrometry (MS)
Clinical Significance: Buprenorphine (Subutex ®) and buprenorphine and naloxone (Suboxone ®) are used to treat opioid dependence (addiction to opioid drugs, including heroin and narcotic painkillers). Buprenorphine is in a class of medications called opioid partial agonist-antagonists, and naloxone is in a class of medications called opioid antagonists. Buprenorphine alone and the combination of buprenorphine and naloxone prevent withdrawal symptoms when someone stops taking opioid drugs by producing similar effects to these drugs
Custom Panel: No

PRODUCTION SCHEDULE

Turn Around Time: 3 to 5 days
Days Performed: Monday, Tuesday, Wednesday, Thursday, Friday, Saturday
Departments:
Sites Performed: Quest - Chantilly
PHL Test Code: SUBS
EPIC Test Code: LAB3137
Send Out Test Code: 16314
Alternate Test Names: Suboxone
CPT Coding: 80348

Go back to the top of the page.